Considerations about the potential of RGI in biological tumor control applications are centered on low molecular weight oligos obtained from RGI galactan side chains, because there is evidence supporting its participation on cellular signaling being good candidates for binding to Galectin 3 (Gal3) [4]. The gene discussed is LGALS3; the disease is neoplasm.